Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, December 9 at 2:00 PM ET

Register Free →

REHYDRATION SALTS FOR

Open
SPE2DP-27-T-0405Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

General Info

NAICS

325411 - Medicinal and Botanical Manufacturing

Place of Performance

PSC 814 BOX 11, APO, AE, 09865-0061, USA

Set-Aside

NONE

Documents

1
PDF

Read the document

Due in 6 days

Every page of every file, in your free workspace.

Read the document

AI Contract Breakdown

Uniform Contract Format

Contract not broken down yet

CLEATUS splits the solicitation into Uniform Contract Format (UCF) sections: scope, pricing, deliverables, and evaluation criteria.

Due in 6 days

Everything you need to bid on this one

Open the full contract in your free workspace.

  • 1 solicitation documentRead every page
  • Buyer contactEmail and phone
Open the full contract

Ask CLEATUS

I've read this contract. Ask me anything.

Timeline

PhaseSolicitation
Posted

Solicitation

Response Deadline

Submission deadline

Response Deadline

Ready to pursue this opportunity?

Get full access to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
Contacts1 person available
OfficeUSA

Full Description

Show more
REHYDRATION SALTS FOR ORAL SOLUTION
REHYDRATION SALTS FOR ORAL SOLUTION. LEMON FLAVORED ELECTROLYTE ORAL
HYDRATION POWDER 400G POUCH 12 PACKETS PER CASE (2.5 GALLON)
RECONSTITUTION WITH WATER IS REQUIRED. UNIT OF ISSUE (1) CASE LABEL
AND MARKINGS SHALL BE IAW MEDICAL MARKING STANDARD 1C.
APPLICABLE TO ALL MEDICAL ACQUISITIONS:
PACKAGING AND PACKING SHALL BE COMMERCIAL AS
SPECIFIED IN THE PROCUREMENT DOCUMENT.
EACH COMPLETE UNIT SHALL BE PROPERLY PACKAGED
IN A SUITABLE SEALED UNIT CONTAINER CAPABLE
OF PROTECTING THE CONTENTS FROM DAMAGE AND/OR
BREAKAGE.
UNITS SHALL BE PACKED IN SUITABLE COMMERCIAL
EXTERIOR (SHIPPING) CONTAINERS (EXPORT WHEN
NECESSARY) WHICH SHALL INSURE ACCEPTANCE AND
SAFE DELIVERY BY COMMON OR OTHER CARRIER, AT
THE LOWEST RATE, TO POINT OF DELIVERY CALLED
FOR IN THE CONTRACT OR ORDER.
MATERIAL MUST BE MARKED IAW MEDICAL MARKING
STANDARD NO. 1. THIS SUPERCEDES ALL REFERENCES
TO MIL-STD-129.
COPIES OF MEDICAL MARKING STANDARD NO. 1
(MMS NO. 1) MAY BE OBTAINED BY CONTACTING DLA
TROOP SUPPORT VIA EMAIL TO Sign up to see this detail. MMS NO. 1 IS ALSO AVAILABLE ONLINE AT: https://www.dla.mil/Logistics-Operations/Packaging/
RD003, COVERED DEFENSE INFORMATION POTENTIALLY APPLIES
RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
RA001: THIS DOCUMENT INCORPORATES TECHNICAL AND/OR QUALITY REQUIREMENTS
(IDENTIFIED BY AN 'R' OR AN 'I' NUMBER) SET FORTH IN FULL TEXT IN THE
DLA MASTER LIST OF TECHNICAL AND QUALITY REQUIREMENTS FOUND ON THE WEB
AT:
http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx
FOR SIMPLIFIED ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE SOLICITATION ISSUE DATE OR THE AWARD DATE CONTROLS. FOR LARGE ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE RFP ISSUE DATE APPLIES UNLESS A SOLICITATION AMENDMENT INCORPORATES A FOLLOW-ON REVISION, IN WHICH CASE THE AMENDMENT DATE CONTROLS.
RQ011: REMOVAL OF GOVERNMENT IDENTIFICATION FROM NON-ACCEPTED SUPPLIES
RS020: Shelf-life requirement RS001 for a TYPE I (CODE Q) item with a shelf life of 36 months (non-extendable) applies to this item.
SHALL BE MARKED IAW THE LATEST EDITION OF
THE MEDICAL MARKING STANDARD NO. 1.
MMS NO. 1 IS AVAILABLE ONLINE AT:
https://www.dla.mil/Logistics-Operations/Packaging/
SPE2DP-27-T-0405
SECTION B
DRIP DROP HYDRATION INC. 7KYZ6 P/N 61563
DLA issues this document using the DoD authorized unit of issue, please refer to the following URL to determine the corresponding ANSI X12 unit of issue.
https://view.officeapps.live.com/op/view.aspx?src=https%3A%2F%2Fwww.dla.mil%2FPortals%2F104%2FDocuments% 2FDLMS%2FeApplications%2FLogDataAdmin%2FUnitofIssueandPurchaseUnit.xlsx&wdOrigin=BROWSELINK
CLIN PR PRLI UI QUANTITY UNIT PRICE TOTAL PRICE.
0001 7019181090 0001 CS 4.000
NSN/MATERIAL:6505016711859
DELIVERY (IN DAYS):0020
DELIVER FOB: DESTINATION
QTY VARIANCE: PLUS 0% MINUS 0%
INSPECTION POINT: DESTINATION
ACCEPTANCE POINT: DESTINATION
PREP FOR DELIVERY:
PKGING DATA-QUP:001
IF MATERIAL IS CONSIDERED HAZARDOUS IAW FED-STD-313,
PACKAGE IN ACCORDANCE WITH TQ REQUIREMENT IP025.
IF THE MATERIAL IS NOT CONSIDERED HAZARDOUS, IN ACCORDANCE WITH
FED-STD-313, THE MATERIAL SHALL BE COMMERCIALLY PACKAGED IN ACCORDANCE
WITH ASTM D3951.
All DLA Master List of Technical and Quality Requirements take precedence over ASTM D3951. Mark and label all packaging and packing in accordance with MIL-STD-129. The Unit of Issue (U/I) and Quantity per Unit Pack (QUP) will be as specified in the contract/purchase order. PALLETIZATION SHALL BE IN ACCORDANCE WITH RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
PARCEL POST ADDRESS:
N49014
PUBLIC WORKS DEPARTMENT SOUDA BAY
PSC 814 BOX 11
APO AE 09865-0061
US
FOR TRANSPORTATION SEE DLAD DLAD PROC NOTE C19. FOR FIRST DESTINATION TRANSPORTATION SEE DLAD PROC NOTE
C20 AND CONTRACT
FREIGHT SHIPPING ADDRESS:
N49014
PUBLIC WORKS DEPARTMENT SOUDA BAY
BUILDING 54 AMERICAN BASE
CHANIA GREECE
MOUZOURAS AKROTIRIU
SPE2DP-27-T-0405
SECTION B
PR: 7019181090 PRLI: 0001 CONT’D
GR
M/F: (TCN) N331916222001C
RDD: 252
PROJ: MP5 TP 3
SUPP ADD: N49014 SIG: J
FOR GOVERNMENT USE ONLY: (IPD) 14
DIC: A41 DIST: 9B ADV: 2A FC: X2
Need Ship Date:00/00/0000 Original Required Delivery Date:08/18/2026
SPE2DP-27-T-0405 NSN/Part Number: 6505-01-671-1859 Quantity: 4 CS Purchase Request: 7019181090QTY: 4 Delivery: 20 days ADO

Similar Contracts

Same NAICS industry code

NAICS: 325411
New
Federal
Reagent Generation for Bioanalytical Method Development on Biologics Therapeutics
Solicitation # 75N98027R00020
The National Center for Advancing Translational Sciences within the National Institutes of Health has issued a Sources Sought notice for an IDIQ contract focused on reagent generation for bioanalytical method development on biologics therapeutics. The primary objective is to identify qualified sources capable of generating and delivering high-affinity, specific anti-drug antibodies, including neutralizing antibodies and antibodies against carriers or gene-of-interest protein products. These reagents will support the quantification of novel biologic drugs in biological matrices such as plasma, serum, and tissue homogenates. The anticipated scope includes the production of polyclonal and monoclonal antibodies, specificity characterization, and the delivery of purified antibodies at an estimated scale of 10 to 50 mg per reagent. The required performance standards are rigorous, demanding adherence to US FDA current Good Manufacturing Practice, Good Laboratory Practice, and Good Clinical Practice, as well as ICH and ISO regulations. Contractors must maintain a comprehensive Quality Management Plan and an independent Quality Assurance Unit to ensure all products meet strict quality requirements. Additional requirements include the development of standard operating procedures for packaging and shipping, the maintenance of secure facilities with restricted access, and the implementation of contingency plans for catastrophic events. The anticipated period of performance for this effort is ten years. Interested respondents must be registered in the System for Award Management and provide a capability statement under NAICS code 325411 by November 30, 2026.
National Institutes Of Health Nida

POSTED

1 day ago

DEADLINE

in 13 days
View Details
NAICS: 325411
New
DIBBS
ANALGESIC GEL, TOPICAL
Solicitation # SPE2DP-27-T-0371
Solicitation SPE2DP-27-T-0371 is a Request for Quotations issued by the DLA Troop Support Medical Supply Chain Pharm FSA for the procurement of Biofreeze topical analgesic gel. The requirement consists of four units of colorless gel containing 5% Menthol USP in 4 oz (118ml) tubes, intended for use by adults and children aged two years and older. The product is classified as a Type I (Code M) item with a non-extendable shelf life of 24 months and must be stored in a cool, dry place between 20-25 C (68-77 F) away from direct sunlight. Due to its flammable nature, the gel must be kept away from excessive heat or open flames. Delivery is specified as FOB Destination to the 0024 QM Co Composite Suppl at Joint Base Lewis MCCH, WA, with a required delivery date of November 16, 2026, and a delivery window of 20 days. Packaging must follow MIL-STD-2073-1E and RP001 DLA packaging requirements, utilizing suitable sealed unit containers and commercial exterior shipping containers. Marking must strictly adhere to Medical Marking Standard No. 1, which supersedes MIL-STD-129. The contract incorporates various FAR and DFARS clauses, including requirements for equal opportunity for workers with disabilities, safeguarding covered defense information, and compliance with the Buy American Act and Berry Amendment. Invoicing and payment must be processed electronically through the Wide Area WorkFlow (WAWF) system.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

2 days ago

DEADLINE

in 6 days
View Details
NAICS: 325411
New
DIBBS
KETOROLAC TROMETHAMINE
Solicitation # SPE2DP-27-T-0291
This procurement, solicitation SPE2DP-27-T-0291, is a small business set-aside issued by the DLA Troop Support Medical Supply Chain Pharm FSA for the acquisition of Ketorolac Tromethamine Injection. The requirement is for 10 packages of USP 15 mg per ml solution provided in pre-filled syringes, identified by NSN 6505-01-666-2156. The product is classified as a Type I (Code M) item with a non-extendable shelf life of 24 months. Delivery is required FOB Destination to the 1AD Sustainment Brigade SSA at Fort Bliss, Texas, with a required delivery date of November 13, 2026, and a delivery timeline of 20 days. The contract mandates strict adherence to Medical Marking Standard No. 1, which supersedes MIL-STD-129 for medical marking, although MIL-STD-129 remains applicable for general shipment and storage. Packaging must be commercial and include suitable sealed unit containers, with specific requirements for hazardous materials under FED-STD-313 and TQ requirement IP025. Suppliers must submit Safety Data Sheets and Hazard Communication Standard labels for review prior to award. Inspection and acceptance will occur at the destination. Administrative requirements include the use of the Wide Area WorkFlow system for invoicing and compliance with various FAR and DFARS clauses regarding cybersecurity, domestic preferences, and small business representations.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

5 days ago

DEADLINE

in about 22 hours
View Details

More opportunities from Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

Same awarding agency

Ready to Pursue This Opportunity?

Get AI-powered intelligence on this solicitation and the ones like it

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS